BeiGene, Ltd. American Depositary Shares

The Waldenstrom macroglobulinemia market is experiencing steady growth driven by advances in targeted therapies, particularly BTK inhibitors. Rising awareness, improved diagnostics, and increasing clinical trials are propelling market expansion, with several emerging drugs showing promise in treating this rare lymphoma.

Related tickers: CLRB, BGNE, ONC, MRK, NRIX.

Ascentage Pharma announced the appointments of Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance to support the company's global expansion strategy.

Related tickers: AAPG, TAK, BGNE, ONC, NVS.